178 related articles for article (PubMed ID: 24909570)
1. In vitro and in vivo evaluation of two carrageenan-based formulations to prevent HPV acquisition.
Rodríguez A; Kleinbeck K; Mizenina O; Kizima L; Levendosky K; Jean-Pierre N; Villegas G; Ford BE; Cooney ML; Teleshova N; Robbiani M; Herold BC; Zydowsky T; Fernández Romero JA
Antiviral Res; 2014 Aug; 108():88-93. PubMed ID: 24909570
[TBL] [Abstract][Full Text] [Related]
2. Carrageenan is a potent inhibitor of papillomavirus infection.
Buck CB; Thompson CD; Roberts JN; Müller M; Lowy DR; Schiller JT
PLoS Pathog; 2006 Jul; 2(7):e69. PubMed ID: 16839203
[TBL] [Abstract][Full Text] [Related]
3. Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types.
Kwak K; Jiang R; Wang JW; Jagu S; Kirnbauer R; Roden RB
PLoS One; 2014; 9(5):e97232. PubMed ID: 24816794
[TBL] [Abstract][Full Text] [Related]
4. Griffithsin carrageenan fast dissolving inserts prevent SHIV HSV-2 and HPV infections in vivo.
Derby N; Lal M; Aravantinou M; Kizima L; Barnable P; Rodriguez A; Lai M; Wesenberg A; Ugaonkar S; Levendosky K; Mizenina O; Kleinbeck K; Lifson JD; Peet MM; Lloyd Z; Benson M; Heneine W; O'Keefe BR; Robbiani M; Martinelli E; Grasperge B; Blanchard J; Gettie A; Teleshova N; Fernández-Romero JA; Zydowsky TM
Nat Commun; 2018 Sep; 9(1):3881. PubMed ID: 30250170
[TBL] [Abstract][Full Text] [Related]
5. In vitro inhibition of human papillomavirus following use of a carrageenan-containing vaginal gel.
Novetsky AP; Keller MJ; Gradissimo A; Chen Z; Morgan SL; Xue X; Strickler HD; Fernández-Romero JA; Burk R; Einstein MH
Gynecol Oncol; 2016 Nov; 143(2):313-318. PubMed ID: 27625046
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with human papillomavirus pseudovirus-encapsidated plasmids targeted to skin using microneedles.
Kines RC; Zarnitsyn V; Johnson TR; Pang YY; Corbett KS; Nicewonger JD; Gangopadhyay A; Chen M; Liu J; Prausnitz MR; Schiller JT; Graham BS
PLoS One; 2015; 10(3):e0120797. PubMed ID: 25785935
[TBL] [Abstract][Full Text] [Related]
7. A novel intravaginal ring to prevent HIV-1, HSV-2, HPV, and unintended pregnancy.
Ugaonkar SR; Wesenberg A; Wilk J; Seidor S; Mizenina O; Kizima L; Rodriguez A; Zhang S; Levendosky K; Kenney J; Aravantinou M; Derby N; Grasperge B; Gettie A; Blanchard J; Kumar N; Roberts K; Robbiani M; Fernández-Romero JA; Zydowsky TM
J Control Release; 2015 Sep; 213():57-68. PubMed ID: 26091920
[TBL] [Abstract][Full Text] [Related]
8. Surfactant Protein A Impairs Genital HPV16 Pseudovirus Infection by Innate Immune Cell Activation in A Murine Model.
Ujma S; Carse S; Chetty A; Horsnell W; Clark H; Madsen J; Mackay RM; Watson A; Griffiths M; Katz AA; Schäfer G
Pathogens; 2019 Dec; 8(4):. PubMed ID: 31817644
[No Abstract] [Full Text] [Related]
9. In vivo longitudinal imaging of experimental human papillomavirus infection in mice with a multicolor fluorescence mini-endoscopy system.
Mitsunaga M; Kosaka N; Kines RC; Roberts JN; Lowy DR; Schiller JT; Ishihara Y; Hasegawa A; Choyke PL; Kobayashi H
Cancer Prev Res (Phila); 2011 May; 4(5):767-73. PubMed ID: 21430072
[TBL] [Abstract][Full Text] [Related]
10. Carrageenan as a Preventive Agent Against Human Papillomavirus Infection: A Narrative Review.
Laurie C; El-Zein M; Coutlée F; de Pokomandy A; Franco EL
Sex Transm Dis; 2021 Jul; 48(7):458-465. PubMed ID: 33433173
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a Carrageenan gel Against Transmission of Cervical HPV (CATCH): interim analysis of a randomized, double-blind, placebo-controlled, phase 2B trial.
Magnan S; Tota JE; El-Zein M; Burchell AN; Schiller JT; Ferenczy A; Tellier PP; Coutlée F; Franco EL;
Clin Microbiol Infect; 2019 Feb; 25(2):210-216. PubMed ID: 29684633
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic immunization with human papillomavirus vaccines induces oral immunity in mice.
Ahn J; Peng S; Hung CF; Roden RBS; Best SR
Laryngoscope; 2018 Jan; 128(1):E16-E20. PubMed ID: 28868617
[TBL] [Abstract][Full Text] [Related]
13. 'Secondary prevention' against female HPV infection: literature review of the role of carrageenan.
Calagna G; Maranto M; Paola C; Capra G; Perino A; Chiantera V; Cucinella G
Expert Rev Anti Infect Ther; 2020 Sep; 18(9):865-874. PubMed ID: 32552158
[No Abstract] [Full Text] [Related]
14. The effectiveness of Carraguard, a vaginal microbicide, in protecting women against high-risk human papillomavirus infection.
Marais D; Gawarecki D; Allan B; Ahmed K; Altini L; Cassim N; Gopolang F; Hoffman M; Ramjee G; Williamson AL
Antivir Ther; 2011; 16(8):1219-26. PubMed ID: 22155903
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy in new pre-clinical models of HPV-associated oral cancers.
Paolini F; Massa S; Manni I; Franconi R; Venuti A
Hum Vaccin Immunother; 2013 Mar; 9(3):534-43. PubMed ID: 23296123
[TBL] [Abstract][Full Text] [Related]
16. Enhanced mucosal and systemic immune responses following intravaginal immunization with human papillomavirus 16 L1 virus-like particle vaccine in thermosensitive mucoadhesive delivery systems.
Park JS; Oh YK; Kang MJ; Kim CK
J Med Virol; 2003 Aug; 70(4):633-41. PubMed ID: 12794729
[TBL] [Abstract][Full Text] [Related]
17. Impact of a new carrageenan-based vaginal microbicide in a female population with genital HPV-infection: first experimental results.
Perino A; Consiglio P; Maranto M; De Franciscis P; Marci R; Restivo V; Manzone M; Capra G; Cucinella G; Calagna G
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6744-6752. PubMed ID: 31378918
[TBL] [Abstract][Full Text] [Related]
18. Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan.
Roberts JN; Buck CB; Thompson CD; Kines R; Bernardo M; Choyke PL; Lowy DR; Schiller JT
Nat Med; 2007 Jul; 13(7):857-61. PubMed ID: 17603495
[TBL] [Abstract][Full Text] [Related]
19. Role of seminal plasma in the anti-HIV-1 activity of candidate microbicides.
Neurath AR; Strick N; Li YY
BMC Infect Dis; 2006 Oct; 6():150. PubMed ID: 17042959
[TBL] [Abstract][Full Text] [Related]
20. A murine genital-challenge model is a sensitive measure of protective antibodies against human papillomavirus infection.
Longet S; Schiller JT; Bobst M; Jichlinski P; Nardelli-Haefliger D
J Virol; 2011 Dec; 85(24):13253-9. PubMed ID: 21976653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
